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The structure and function of antiamoebin I, a proline-rich
membrane-active polypeptide
CF Snook†, GA Woolley‡, G Oliva§, Vasantha Pattabhi#, SP Wood¶,
TL Blundell¥ and BA Wallace*
Background: Antiamoebin is a member of the peptaibol family of polypeptides
and has a unique antibiotic activity: it acts as an antiamoebic agent, but does
not effectively haemolyze erythrocytes even though it does exhibit
membrane-modifying activity.
Results:  The structure of antiamoebin I has been determined by X-ray
crystallography at 1.4 Å resolution. The molecule forms a helical structure,
which, as a result of the presence of a number of proline and hydroxyproline
residues, has a deep bend in the middle. Circular dichroism spectroscopy,
single-channel conductance studies and fluorescence diffusion studies suggest
a mode of ion transport that is entirely different from that of the other two
members of the peptaibol family (alamethicin and zervamicin) whose structures
and functions have been examined in detail.
Conclusions: The structure of the polypeptide has been determined and a
functional model for its mode of action in membranes is presented. Although
under some conditions antiamoebin may form ion channels, unlike the closely
related alamethicin and zervamicin polypeptides, its major membrane-modifying
activity appears to be as an ion carrier.
Introduction
Antiamoebin (AAM) I is the major component [1] of a
family of antibiotic peptides that have been shown
to have antiamoebic properties. The antiamoebins were
first discovered during a screen of fungal extracts from
Emericellopsis poonensis against a locally isolated strain of
Entamoeba histolytica following an outbreak of amoebic
dysentery [2].
The antiamoebins have the sequence [1,3]: Ac–Phe–Aib–
Aib–Aib–Iva–Gly–Leu–Aib–Aib–Hyp–Gln–Iva–X–Aib–
Pro–Phl, where X is Hyp in AAMI and Pro in AAMII and
Phl is phenylalaninol. One of the noteworthy features of
the primary structure of this peptide is its high content of
α,α-disubstituted amino acids: α-aminoisobutyric acid (Aib;
α-methylalanine) comprises five of the 16 residues and
isovaline (Iva; α-ethylalanine) comprises two more of the
residues. These types of conformationally restricted amino
acids tend to favour the formation of helical secondary
structure [4]. In addition, AAM contains three imino acids
(Hyp and Pro) with sterically restricted geometries often
considered to be helix breakers. Other important features
of this peptide are the blocked termini: the N terminus is
blocked by an acetyl group and the C terminus is blocked
by the aliphatic alcohol phenylalaninol, which means that
the peptide is uncharged at all values of pH. The blocked
termini led to the original (incorrect) proposal that it was a
cyclic peptide [5].
Initially, isovaline residues in the antiamoebin sequences
were reported to be L-enantiomers [1], but a later study
[6] suggested that these residues were the D-enantiomers.
A three-dimensional model of AAMI was developed
based on NMR data [7] using D-isovalines. The model
had a left-handed N-terminal helical segment and a right-
handed C-terminal helical segment. A series of semi-
empirical energy calculations [8] supported the presence
of the rather unusual left-handed helix. Another model
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for the structure [9] suggested that it would be an entirely
310 right-handed helix.
AAM is a member of the class of peptides known as pep-
taibols — PEPTides containing AIB with an alcohOL ter-
minus. A database of known peptaibol sequences and
structures has been constructed recently and is accessible
at the World Wide Web URL: http://www.cryst.bbk.ac.
uk/peptaibol/welcome.html. Crystal structures have been
determined for three members of the family, alamethicin
Rf-30, Leu1-zervamicin, and trichogin A-VI [10–12], which
are, respectively, 20, 16, and 11 residues in length. The
longer peptaibols tend to form ion channels in vitro with
varying degrees of stability — alamethicin, the longest and
most well-characterized, forming one of the most stable.
The peptaibols that have been tested were found to have
a broad anti-bacterial activity against Gram-positive bacte-
ria, and many (although not AAM) have been shown to be
effective in haemolysis of human erythrocytes [13]. Ala-
methicin, zervamicin and AAM can act as uncouplers of
mitochondrial oxidative phosphorylation [7,14,15]. It is
thought that their biological activities result from mem-
brane-modifying properties, specifically that they form
channels that result in the leakage of cytoplasmic material
from the cell and that this ultimately leads to cell death.
The single-channel conductance properties of alamethicin
have been well-documented [16,17] and the conductances
of the zervamicins have been characterized [18]; there is,
however, no definitive single-channel data for the shorter
members of the family.
In this paper we describe the high-resolution determina-
tion of the X-ray crystal structure of AAMI and compare it
with the structures of other peptaibols. Circular dichroism
(CD) spectroscopy, fluorescence diffusion, and single-chan-
nel conductance measurements have been used to inves-
tigate the functional properties of the molecule. These
properties (as well as AAM’s biological activities) are con-
trasted with those of the two other well-characterized long
peptaibols (alamethicin and zervamicin) and, as a result, a
very different model is proposed to account for the activity
of AAMI in membranes.
Results
Structure determination
The crystal structure of AAMI was solved and refined to
1.4 Å resolution. Because this molecule falls in the awk-
ward ‘intermediate size’ category of peptides, solution of
the structure by typical direct methods used for small mol-
ecules, or multiple isomorphous replacement methods used
for macromolecules, has not been possible to date, despite
the availability of crystal data for more than 10 years [19].
The solution was further complicated by the cylindrical
shape of the molecule and the small solvent volume in
the crystals. It was possible, however, to solve the struc-
ture to high resolution after initial phasing by molecular
replacement using a partial model from a related pep-
taibol. The parameters and considerations for molecular
replacement and refinement of this size molecule differ
somewhat from those used for large proteins, and will be
discussed elsewhere (C.F.S. and B.A.W., unpublished
observations). The data collection and refinement statistics
are given in Table 1. There are two molecules in the P1
asymmetric unit related by a non-crystallographic twofold
axis (Figure 1).
Structure description
In the asymmetric unit of the crystal there are two inde-
pendent molecules, which are referred to in this paper as
A and B. The conformations of the two chains are very
similar: the Cα positions of the A and B chains have a root
mean square deviation (rmsd) of 0.415 Å. The largest
deviations involve residues 1–5, for which the rmsd is
0.443 Å. The major difference between the structures of
the two molecules is the bend angle in the helix. The A
molecule had a larger bend angle (56°) than the B mol-
ecule (48°). The other major difference between the A
and B molecules, only clearly distinguishable when the
refinement included all data to a resolution limit of 1.4 Å,
was the disorder found in the N terminus of the B chain,
which was not seen in the A chain. The first five residues
of B appear to adopt two distinct conformations, which are
present in an approximate ratio of 9:1. To simplify matters,
and because the structures are generally very similar, in
this paper discussions of the B chain structure will refer
only to the major conformation detected and when only
one structure is referred to, it will be that of the better
defined (lower B-factor) molecule A.
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Table 1
Data collection and refinement.
Space group P1
Molecules/asymmetric unit 2
Unit cell
a = (Å) 26.52
b = (Å) 28.82
c = (Å) 9.06
α = (°) 88.90
β = (°) 96.64
γ = (°) 123.85
Number of non-hydrogen atoms
peptide 238
solvent 30
R-factor 0.156
Resolution range (Å) 25.0–1.4
Reflections with F > 0σ 4359
Completeness 97.3%
R-merge 0.012
Rmsd values
bond lengths 0.014
bond angles 3.638
dihedral angles 23.140
improper angles 8.489
Average B-factor (Å2) 8.08
The entire structure of AAMI can be classified as a right-
handed helix, according to its phi/psi backbone torsion
angles. According to PROCHECK [20], only one residue,
Aib3B, lies outside the most favourable region. The helix
contains three segments with different secondary struc-
tural motifs [21]: residues 1–9 which form an α helix,
residues 10–12, which form a 310 helix, and residues 12–16
(Figure 2). Although residues 12–16 contain i + 3 → i type
hydrogen bonds normally found in 310 helices (Table 2), as
a result of breaks in the hydrogen bonding pattern caused
by two imino acids (Hyp13 and Pro15), this segment actu-
ally should be considered to be two overlapping type I
β turns.
The AAM helix is bent at the Hyp10 position, the same
position of the bend in the Leu1-zervamicin structure [11]
and analogous to the bend at Pro14 in the alamethicin
Rf-30 structure [10]. The bend angles for both AAM mol-
ecules are considerably larger than those for either Leu1-
zervamicin or alamethicin (Table 3). Alamethicin Rf-30
shows a 12° variation between the three different mol-
ecules in the same crystallographic unit cell, Leu1-zer-
vamicin exhibits helix bends with a difference of 15° in
the three different crystal forms it has been examined in,
and AAMI shows a variation of 8° between the two inde-
pendent molecules in the same crystal. Molecular dynam-
ics simulations on alamethicin have shown that bending
can be accommodated without substantial distortion to the
helical backbone [22]. Although there may be some flexi-
bility about the bend in all three peptaibols, it is clear that
the AAMI bends are, on average, much larger than the
bends in any of the other structures. The large bend angle
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Figure 1
Intermolecular interactions in the AAMI crystal. (a) Packing of AAMI
monomers and solvent molecules in the P1 crystal. The A and B chains
are shown in pink and blue, respectively. Atoms are shaded according
to B-factors, with the lightest ones having the lowest values.
(b) Relationship between the A (left) and B (right) monomers (dark
grey) in an asymmetric unit, showing the intermolecular hydrogen
bonds. The adjacent molecules in the unit cell are depicted in white to
show the end-to-end hydrogen bonds present.
in AAMI results in a molecule whose length (28 Å) is
somewhat shorter than either of the other molecules (29 Å
and 34 Å).
AAMI and AAMII differ only in the nature of the residue
found at position 13, which in AAMI is hydroxyproline but
in AAMII is proline. Prior to determining the structure, we
were unsure of which isoform the crystals contained. The
electron density map (Figure 3a) clearly shows, however,
that the residue at position 13 is hydroxyproline, demon-
strating that the peptide is AAMI. Before this structure
determination, it was unclear whether the peptide con-
tained D-isovaline or L-isovaline, as there were conflicting
reports in the chemical literature as to the chiral nature of
these residues. The maps (Figure 3b) unambiguously
show that the isovaline residues are all D-conformers, con-
firming the chirality assignments made by Bruckner and
Przybylski [6]. The proline and hydroxyprolines all adopt
trans peptide bonds with the hydroxyl groups in the ‘up’
position for both hydroxyprolines.
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Figure 2
Two views (from the same direction) of the structure of AAMI
(monomer A). (a) A stereo view showing all non-hydrogen atoms. This
figure was drawn using RASMOL [48]. (b) A ribbon model showing the
different types of helical secondary structures present: N-terminal ribbon
(top), α helix; thin worm (centre), 310 helix; C-terminal thick worm
(bottom), series of β turns. This figure was drawn using SETOR [49].
Table 2
Antiamoebin I and Leu1-zervamicin sequences and
intramolecular backbone hydrogen bonds.
Hydrogen bonds NH O
AAMI Iva5 Phe1
Gly6 Aib2
Leu7 Aib3
Aib8 Aib4
Aib9 Iva5
Gln11 Aib8
Iva12 Aib9
Aib14 Gln11
Phl16 Hyp13
ZER Iva4 Ac0
Ile5 Leu1
Thr6 Ile2
Aib7 Gln3
Leu8 Iva4
Aib9 Ile5
Gln11 Leu8
Aib12 Aib9
Aib14 Gln11
Phl16 Hyp13
AAMI, antiamoebin I; ZER, Leu1-zervamicin. AAMI sequence:
Ac–Phe–Aib–Aib–Aib–Iva–Gly–Leu–Aib–Aib–Hyp–Gln–Iva–Hyp–
Aib–Pro–Phl. ZER sequence: Ac–Leu–Ile–Gln–Iva–Ile–Thr–Aib–Leu–
Aib–Hyp–Gln–Aib–Hyp–Aib–Pro–Phl.
Table 3
A comparison of the geometries of the peptaibols.
Dipole
Bend angle Length moment α*
Sample (°) (Å) (Debyes) (°)
AAMI A chain 56.0 28.3 54.1 45
Leu1-zervamicin [11] 37.8 29.0 53.2 30
Alamethicin Rf-30 A chain [10] 33.3 33.7 80.2 33
*The angle the dipole moment direction makes relative to the helix axis
of the N-terminal helix of the peptide (0° would correspond to parallel
to the helix axis, a value of 90° would be perpendicular to the helix axis).
Intermolecular interactions
The two monomers pack in the unit cell like two Vs abut-
ting to form an X with hetero-intermolecular hydrogen
bonding patterns stabilizing this motif (Figure 1). The
Hyp10 hydroxyl group on chain B forms hydrogen bonds
with the backbone carbonyl oxygen of Leu7 on chain A
and with the ε-amino group of Gln11 on chain A. The
peptides also form homo-intermolecular hydrogen bonds
that stabilize the interactions between molecules in differ-
ent unit cells. These interactions occur as the termini of
the peptides form head-to-tail bonds. The interactions are:
Pro15′(O)→Phe1(N), Phl16′(OH)→Aib3(N) and Ace′′(O)→
Phl16(OH), where ′ and ′′ indicate that these are from the
adjacent unit cells on either side, respectively.
At the present resolution, only 25 fully occupied methanol
molecules are observed (out of a theoretical maximum of
260). Of these, only seven form hydrogen bonds with the
peptides. The remainder appear to form a network of
hydrogen-bonded solvent molecules. The packing of the
two peptides in the unit cell is such that a hydrophilic
region is formed by the divergent termini in each unit cell.
The stacking of the unit cells allows the formation of a
hydrophilic channel between four peptides and this is the
region of the unit cell where most of the highly ordered
methanols are observed.
A comparison of the structure with other models for AAMI
Prior to this crystallographic determination, three models
had been proposed for the structure of AAM. The first was
based upon NMR studies in dimethylsulphoxide [7,23],
from which AAM was found to contain a left-handed helix
in the N-terminal segment (residues 2–6), followed by a
type II β turn at Leu7–Aib8, and a right-handed helix in
the C-terminal segment (residues 9–16). The second model,
based on semi-empirical energy calculations, had a left-
handed helix up to residue 7, with a non-helical C terminus
[8]. The present structure clearly contradicts these models,
in that no left-handed helix is present, as can be seen in the
Ramachandran plot (available as supplementary material
with the internet version of this paper).
An alternative model [9] for the hydrogen-bonding pattern
of AAM was proposed based upon the crystal structure of
a synthetic nonapeptide fragment of AAM [24] and the
sequence and unit cell dimension similarities to Leu1-zer-
vamicin. It was proposed that AAM would be an entirely
310 helix. The observed hydrogen-bonding pattern in the
crystal differs from this considerably, however.
A comparison with the structures of other peptaibols
A comparison has been made of the AAMI structure with
the structures of the two other naturally occurring peptai-
bols that exhibit a bent helical topology, namely alamethi-
cin Rf-30 [10] and Leu1-zervamicin [11]. Zervamicin has
the same number of residues as AAM, with six of the last
seven residues being identical (the only exception is a
substitution of Aib for Iva). The hydrogen-bonding pat-
tern (Table 2) for AAMI was essentially identical to the
pattern observed for Leu1-zervamicin (except that the
Ac0–Iva4 bond was missing in AAM). Both differ from the
predominantly α-helical hydrogen-bonding pattern found
in alamethicin Rf-30.
AAMI is ~1 Å shorter than Leu1-zervamicin, even though
they contain the same number of residues; both are much
shorter than the alamethicin molecule, which has three resi-
dues more (Table 3). Like zervamicin, AAM contains three
imino acids, whereas alamethicin contains only a single pro-
line. The angles of the helical bends of both antiamoebin
molecules were greater than those observed for alamethicin
and zervamicin (Table 3); the bend accounts for the shorter
length of AAM when compared with zervamicin.
Another consequence of the different bend angle is that
the helix dipole moments differ in the three molecules;
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Figure 3
Electron density maps of the regions around
(a) Hyp13, showing that it is hydroxyproline
and not proline, and (b) Iva12, showing that it
is the D-enantiomer. The maps are contoured
at 0.8 e–/Å3 (red) and 2.0 e–/Å3 (blue).
this might have some bearing on their different functional
properties. This (as well as the amino acid sequence)
could influence the nature of the interaction between the
peptide and the electric field generated by the transmem-
brane potential. The magnitudes of the calculated dipole
moments (Table 3) of the three peptaibols are roughly
related to the number of residues in the structure, but the
directions of the dipole moments from the helical axis of
the N-terminal segment helix are very different. For AAMI,
the direction essentially bisects the bend angle, whereas
for the other two, it aligns more closely with the helix axis.
Circular dichroism spectroscopy
Because the crystals of AAM were grown from methanol,
one valid question to ask regarding the structure is: what is
its relevance to the structure as found in membranes? One
way of answering that question is to compare the structures
found in the two different environments using a single
physical technique. CD spectroscopy was therefore used to
examine the spectra of AAM in methanol and in small uni-
lamellar vesicles (SUVs) made of dimyristoyl phosphatidyl-
choline (DMPC), and to compare the calculated secondary
structures in these environments with the secondary struc-
tures found in the crystal structure. The spectra of AAM in
methanol and bound to SUVs have very similar shapes
(Figure 4), and are characteristic of peptides with high
helical contents. The calculated secondary structure con-
tents derived from these spectra (Table 4) suggest that
under both conditions, much of the molecule is helical; in
the case of the methanol, ~10 residues are helical and the
rest — six residues — form β turns. In SUVs, this corre-
sponds to eight residues of helix and six residues of β turn.
The major difference appears to be that two residues in the
SUVs adopt more disordered structures than they do either
in the crystal or in the methanol solution. Although it is
possible that crystal packing forces could alter the structure
in the solid state, the calculated values for the methanol
solution correlate exceedingly well with the crystal sec-
ondary structure (calculated using PROMOTIF [25]), and
tend to give credence to the crystal structure as being
generally representative of the type of structure found in
solution and in the membrane-bound state.
This result is very different from that observed for alame-
thicin [26], in which the shapes of the CD curves in the
crystallization solvent (methanol/acetonitrile) and in SUVs
were very different, as were the calculated secondary struc-
tures derived from them. Furthermore, the CD-derived
secondary structure from the crystallization solvent sample
did not correlate well with the secondary structure seen in
the crystal. This would tend to suggest that alamethicin
undergoes a significant change from that seen in the crystal
when it binds to membranes, which must be taken into
consideration in producing a function-based model for it.
In the case of AAM, it appears that such a large change
need not be incorporated into any model.
AAM function
In order to examine if AAM does exhibit membrane-mod-
ifying activity, two separate types of experiments were
undertaken. The first, a bulk diffusion assay, was to deter-
mine if AAM can permit the flow of ions across a phospho-
lipid membrane. The second type of experiment, a series
of single-channel conductance measurements, was per-
formed to examine whether any flux seen resulted from
channel formation or some other transport mechanism.
The macroscopic diffusion study employed a fluorescence
assay of membrane potential in 1,2-di(9-cis-octandeca-
noic)-sn-glycero-3-phosphatidylcholine (DOPC) vesicles.
Addition of AAM to membranes in which a potential had
been established previously using valinomycin and a KCl
gradient (Figure 5, curve A), resulted in an exponential
decay of the fluorescence with time (Figure 5, curve B),
where the decay constant depended on the AAM concen-
tration. This indicates that AAM is capable of dissipating a
788 Structure 1998, Vol 6 No 6
Figure 4
Circular dichroism spectra of AAMI in methanol and in small unilamellar
DMPC vesicles.
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Table 4
A comparison of calculated secondary structures.
Structure Crystal Methanol* SUVs*
Helix 69 65 50
Sheet 0 0 0
Turn 31 35 37
Disordered 0 0 14
NRMSD – 0.220 0.193
*From circular dichroism data. NRMSD, normalized rmsd.
transmembrane potential. When the same type of mem-
brane sample was treated with alamethicin, a qualitatively
different decay curve was observed (Figure 5, curve C).
The alamethicin curve shows a rapid decay followed by a
slower phase in which the magnitude of the initial fluo-
rescence decrease depends on the alamethicin concen-
tration. This indicates that alamethicin and AAM use
different mechanisms to enable ion movement across
lipid membranes under these conditions.
The conductance measurements were carried out first with
bilayers made from lipid extracts of the target organism
Entamoeba histolytica or glycerol monooleate, using the patch
pipette technique of Busath and Szabo [27] in which the
peptide was either added to pre-formed bilayers or to the
patch-forming solution. Later, using diphytanoyl-phosphat-
idylcholine as the lipid, membranes were created using the
black lipid membrane technique of Montal and Mueller
[28]. Conditions for the latter experiment were chosen to
mimic those that had been reported to produce single-
channel recordings for the related zervamicin molecule [18].
Both techniques failed to detect the formation of single
ion-channels by AAMI under the conditions investigated.
The use of alamethicin as a positive control under the same
conditions did produce typical ion channels in both lipid
systems. Thus, these experiments indicate that AAMI does
not form single channels under conditions that produce
single channels for the other peptaibols, suggesting that it
must employ a different mechanism for dispersing mem-
brane potentials than do Leu1-zervamicin and alamethicin.
Discussion
The structure of AAMI is similar to the other peptaibol
structures that have been determined by crystallography
thus far, in that it is primarily helical in nature. The details
of the structure are significantly different, however, in
important ways (most especially the helix bend angle) that
can account for the different functional properties and
reported biological activities of these membrane-active
antibiotics.
The potential diffusion assay clearly showed that AAM
possessed membrane activity that caused a reduction in
the trans-membrane potential. The decay was exponential
and approached a non-baseline plateau asymptotically. The
assay using alamethicin as a standard produced a very dif-
ferent decay curve, in which the initial steep decay was fol-
lowed by a slower decay phase. The use of lipids extracted
from the target organism, Entamoeba histolytica, to form
lipid bilayers in the conductance studies was designed to
mimic the in vivo membrane environment in which AAM
acts. No channels were detected for AAM in either these
lipids or DOPC, but alamethicin did form channels in both
these lipids. This result correlates well with earlier reports
that AAM does not form stable conducting states in black
lipid membranes [13]. The lack of observed AAM channel
formation may be a result of the thickness of the bilayers
formed or a reduction in the fluidity of the bilayer (result-
ing from the lipid phase state), or it may be that AAM
simply does not form ion channels under any conditions.
This latter case is mitigated against by the recent demon-
stration that under certain specific conditions, AAM may
be induced to form channels in bilayers made from some
synthetic lipids (H. Duclohier, C.F.S. and B.A.W., unpub-
lished observations). Thus, the thickness of the bilayer
formed is probably the reason for the lack of channel for-
mation observed in these studies. It should be noted,
however, that both alamethicin and zervamicin form chan-
nels under these conditions. These observations are consis-
tent with both the histological observations of peptaibol
effects on the mosquito L3 larval stage [29], in which
20-mer peptaibols had an LD50 of about 100–130 µg/ml
but shorter peptaibols had LD50 values > 200 µg/ml, and
the low haemolytic activity of AAM, compared with ala-
methicin [13]. The exponential decay observed in the
diffusion experiments is consistent with membrane leak-
age, which occurs with slower kinetics, and could result
from either a membrane disruption mechanism like that
employed by mellitin [30] or an ion carrier mechanism like
that of valinomycin.
The length of peptaibol appears to be a factor in the bio-
logical efficacy of the peptaibol, with longer peptides
being more effective (i.e. alamethicin > antiamoebin; [29]).
The 310 helices in Leu1-zervamicin and AAMI make them
longer than α helices made from equivalent numbers of
amino acids and this lead to the suggestion that although
they were only 16 residues long (rather than the 20 resi-
dues in alamethicin), they might still be able to span the
membrane [9,31,32].
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Figure 5
Fluorescence decay curves for AAMI and alamethicin, showing
dissipation of the membrane potential. A, absence of peptide;
B, 1.56 µM AAMI; and C, 1.58 µM alamethicin. Peptides were added
at the point on the curve marked t = 0.
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Significantly, the dipole moments calculated for AAM
differ in both magnitude and direction from those of ala-
methicin and zervamicin. They suggest that alamethicin
and zervamicin could orient themselves in a manner fav-
ourable to insertion perpendicular to the bilayer in the
presence of a transmembrane potential of sufficient magni-
tude. This would be consistent with the widely accepted
barrel-stave model of ion channel formation for this class
of polypeptides [16,17,31,33]. On the other hand, the dipole
moment of AAMI could result in that polypeptide lying
approximately parallel to the membrane surface even when
a transmembrane potential is present. This would suggest
that if AAM were able to form ion channels, then the
transmembrane potential would have to be large enough
to overcome the misorientation. Hence, we propose that
AAM interacts with membranes in a different manner
than the other two peptaibols to cause leakage or to form
an ion complex that can aid diffusion of ions across the
bilayer. Leakage could result from the alignment of the
amphipathic peptide being relatively parallel to the mem-
brane surface, as a result of the direction of its dipole
moment, producing membrane interactions of the peptide
that induce lipid bilayer packing defects. Alternatively, a
model for the proposal is shown in Figure 6, in which
several AAMs specifically sequester a potassium ion,
creating a hydrophobic shell, which then permits slow
diffusion of the ion across the membrane.
Biological implications
Antiamoebin is a member of the peptaibol family of
antibiotics, which function by enabling the transport of
ions across biological membranes. A number of other
members of this family of polypeptides have been studied
as model systems for examining the molecular nature of
ion transport and peptide–bilayer interactions.
The sequence similarity of antiamoebin to the ion-chan-
nel-forming peptaibol zervamicin leads to the expectation
that antiamoebin I would transport ions by forming ion
channels in a similar manner. The present structural
and functional studies have, however, led to the conclu-
sion that antiamoebin is a membrane-modifying, but not
a channel-forming, polypeptide under conditions that
produce Leu1-zervamicin channels. These results are
consistent with both its structure (it is shorter as a result
of the presence of a deep bend in the middle of its long
helix) and its biological activity of ion transport across
membranes without being able to effectively haemolyze
erythrocytes. This study further shows how subtle three-
dimensional structural changes can lead to functional
variations in closely related polypeptides.
Materials and methods
Materials
Spectroscopic grade methanol, dimethylsulphoxide, n-decane and n-pen-
tane were obtained from Aldrich Chemical Co., USA. Diphytanoyl-phos-
phatidylcholine, DOPC and glycerol monooleate were from Avanti Polar
Lipids, USA, and alamethicin and Safranin O were purchased from
Sigma Chemical Co., St. Louis, USA. The DMPC used for spectroscopic
measurements was obtained from Calbiochem.
The peptide used for the crystallization experiments was a generous
gift (to V.P.) from R.K. Nanda of Hindustan Antibiotics, Pune, India. The
peptide was purified according to the protocol of Thirumalachur [2].
The peptide used for the functional studies was purchased from Sigma
(UK) and further purified by HPLC following the protocol of Das et al.
[7]. The purified peptide was checked by mass spectrometry and
shown to have an Mcalc = 857, corresponding to the doubly charged
species of M+ + H20 + Na+.
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Figure 6
A proposed model for ion complex formation with AAM, one possible
mechanism to account for the ion transport properties of this molecule.
In this model, the shaded tube represents the central bend region of
the molecule, and the black bars represent the chelation sites (possibly
sidechain oxygens of Hyp10 or Gln11). For diagrammatic purposes, the
model is shown with six AAM molecules per complex; the stoichiometry
of the complex or complexes that may form is at present unknown.
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Extracellular
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Structure
Crystallization
The peptide was dissolved in spectroscopic grade methanol at a con-
centration of 170 mg/ml. The solution was then gently heated to ~30°C
and allowed to cool slowly in a closed container. The resulting crystals
had a needle morphology with dimensions of 0.4× 0.15 × 0.1 mm [19].
Data collection
The crystal was mounted in a sealed capillary with surrounding mother
liquor. Data were collected on a four-circle diffractometer using nickel-
filtered copper Kα radiation from a sealed tube X-ray generator. The
data collection and processing statistics are presented in Table 1. The
space group was determined to be P1 by precession photography
[19], with unit cell dimensions of a = 26.53 Å, b = 28.82 Å, c = 9.06 Å,
α = 88.90°, β = 99.64° and γ = 123.85°.
Molecular replacement
The search model used for molecular replacement was based upon the
crystal structure of Leu1-zervamicin [11] using residues 6–16, with the
non-equivalent residue sidechains reduced to alanines. This model rep-
resented 62% of the non-hydrogen atoms in the AAMI structure. Mol-
ecular replacement was done with normalized structure factors obtained
from ECALC [34], using AMoRe (CCP4 version; [35]) to obtain rotation
function solutions. The self rotation function indicated the presence of
two molecules in the asymmetric unit. The translation function was cal-
culated using TFFC [34]. Prior to rigid-body refinement, the molecular
replacement solution produced an R-factor of 0.480. A more detailed
description of the molecular replacement will be published elsewhere
(C.F.S. and B.A.W., unpublished observations). The solutions were
checked for packing using the program O [36].
Model building and refinement
Initial rigid-body refinement using XPLOR [37], with 8.0–2.5 Å resolu-
tion data, produced an R factor of 0.426. The missing residues were
added to the model (as alanines) using O [36], one at a time. After each
addition, a cycle of rigid-body refinement was done followed by constant
temperature molecular dynamics in XPLOR [37]. Once all residues had
been built in initially as alanines and then changed to the proper
sidechains, a full round of individual structure factor refinement with sim-
ulated annealing (to 4000K) was carried out, resulting in an R-factor of
0.251. This procedure was carried out for a further 22 cycles during
which the high resolution data was extended from 2.5 Å to 2.0 Å, the
low resolution data limit was extended from 8.0 Å to 25.0 Å and the
intensity cut-off reduced from 2σ to 0σ. During these cycles the remain-
ing atoms were added to suitable electron density. At this stage the
R-factor was 0.178. The refinement was then continued using the full-
matrix least-squares refinement method of SHELXL-93 [38]. During this
phase of the refinement the high resolution limit was extended to 1.4 Å
and isotropic temperature factor refinement was included. The final
model contains 238 non-hydrogen protein atoms and 30 methanol
atoms, and has an R-factor of 0.156 for all data. The model was
checked for stereo-chemical integrity using PROCHECK [20] after
renaming the non-standard amino acid residues to their standard
residue counterparts (i.e. Aib→Ala, D-Iva→Ala and Hyp→Pro). The
Ramachandran plot showed that all residues had phi/psi angles that
were in the allowed region for a right-handed helix. The sidechain of
Phe1 of the B-chain was only partially observed and the polypeptide
backbone for residues 1–5 of the B chain appeared to adopt two differ-
ent conformations, with the one presented here being the dominant one
(~90% of the total). This disorder only became fully apparent in the
electron density map when high resolution (1.4 Å) data was included.
Bend angles in the helices were defined as the angles between the two
planes formed by the mainchain nitrogen atoms of residues 8, 6 and 4
and residues 11, 13 and 15, respectively. The same residue positions
were used in Leu1-zervamicin and equivalent positions in alamethicin
Rf-30 to compare the bend angles. The hydrogen bonds present were
defined according to the program PROMOTIF [25]. Dipole moments
were calculated using default parameters in the program QUANTA [39]
with CHARMm (v23) force fields. The coordinates have been deposited
as entry 1JOH in the Brookhaven Protein Data Bank.
Preparation of lipid extracts from Entamoeba histolytica
Entamoeba histolytica HM-1 amoeba were grown axenically using the
procedure of Diamond [40] in 250 ml tissue culture flasks to a mean cell
count of 1.6 × 107. The cells were harvested by chilling the flasks on ice
for 1 h followed by centrifugation at 700 × g. The membranes were then
isolated according to the procedure of Serrano et al. [41] resulting in a
colourless opaque pellet. The lipids were then extracted from the pellet
using a modified Folch procedure [42]. 6.5 mg of lipid was produced
from 2 × 108 cells, and stored under liquid nitrogen until required.
Single-channel conductance measurements
The conductance measurements were carried out using two different
methods, as described in Busath and Szabo [27] and Montal and
Mueller [28]. Silver/silver chloride electrodes were connected to an Axo-
patch 1D patch-clamp amplifier with a CV-4B head-stage (Axon Instru-
ments, USA). The amplifier was connected to a 20 MHz oscilloscope
(Model 2120, BK Precision, USA) with the Y-trace set at 0.5 V per divi-
sion and a suitable time base for the X-trace. Data was captured on a
Macintosh Power PC 7100/66 (Apple Computers Inc., USA) via an
ITC-16 interface (Intrutech Group, USA) and analyzed using the pro-
gram Synapse (Synergistic Research Systems, USA). Measurements
were carried out using the purified AAMI, and alamethicin as a standard.
The first method used either glycerol monooleate or the lipid extract at
50 mg/ml in n-decane or in n-hexadecane; a 5 mg/ml solution of diphy-
tanoyl-phosphatidylcholine in n-pentane was used to form the lipid
bilayer over an 80 micron hole for the method of Montal and Mueller.
Formation of small unilamellar vesicles (SUVs)
Stock solutions of small unilamellar vesicles for the CD studies were
formed using the method of Cascio and Wallace [26]. The SUVs for
the fluorescence assay were formed in the presence of 200 mM potas-
sium chloride to produce a solution containing 30 mM DOPC. The
SUVs used in the CD spectroscopic studies were formed in deionized
water, producing a sample containing 15 mM DMPC. The suspensions
were then sonicated in a temperature-controlled bath until the solutions
were clear, and then centrifuged at 12,800 × g.
For the CD experiments, the peptide was added to aliquots of the stock
solution of the SUVs and diluted to the final concentration.
Fluorescence assay
The assay [43] used the fluorescent dye Safranin O to monitor the trans-
membrane voltage established across DOPC SUV’s using valinomycin.
The stock solution of DOPC SUVs was diluted tenfold with 200 mM
sodium chloride. 2 ml of of the diluted solution of SUVs were added to
the cuvette. To this was added Safranin O to give a final concentration of
300 µM and the baseline fluorescence recorded. Valinomycin, dissolved
in dimethylsulphoxide to a final concentration of 90µM, was added to
generate the transmembrane potential; the increase in fluorescence was
recorded until a stable level was obtained. Small volumes (10µl) of meth-
anolic peptide solutions, at different concentrations were added to sepa-
rate preparations and the fluorescence was recorded. The fluorescence
was recorded on a Perkin-Elmer LS50B spectrofluorimeter with excita-
tion at 522 nm and emission at 581 nm, using a 1 cm pathlength cuvette.
Circular dichroism spectroscopy
CD spectra were recorded on an Aviv 62ds spectropolarimeter, using a
detector acceptance angle of > 90°, with a 0.01 cm path length. Data
were collected over a wavelength range of 190–250 nm at an interval of
0.2 nm. Five repeats of each spectra and the equivalent baseline were
collected and subtracted, and smoothed using a Savitsky–Golay algo-
rithm [44]. The spectra were analyzed using a normalized linear least-
squares algorithm [45] with a reference data set derived from soluble
proteins [46]. The quality of the fit of the calculated secondary structure
to the experimental data was determined by the NRMSD parameter [47].
Accession numbers
The coordinates of the peptide AAMI used have the Brookhaven PDB
code IJOH.
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